Tech-Bank(002124)2025-04-08 09:40Financial Performance - The estimated net profit attributable to shareholders for Q1 2025 is expected to be between 115 million and 135 million CNY, representing a year-on-year decline of 77.64% to 80.95% compared to 603.73 million CNY in the same period last year[2][4]. - The estimated net profit after deducting non-recurring gains and losses is expected to be between 95 million and 115 million CNY, a significant improvement from a loss of 454.92 million CNY in the same period last year[2][4]. - The basic earnings per share is projected to be between 0.0518 CNY and 0.0608 CNY, down from 0.2717 CNY in the same period last year[2][4]. - The decline in net profit is primarily due to the previous year's investment gains from the sale of shares in a subsidiary, Shiji Biological[4]. Operational Status - The company has maintained stable operations during the pre-restructuring phase, with improved management and efficiency leading to a significant reduction in pig sales costs[4]. - The company is currently in a pre-restructuring phase, which does not guarantee formal restructuring and carries uncertainties regarding the outcome[6]. Risks and Uncertainties - There is a risk of stock trading being subject to delisting warnings if the court accepts the company's restructuring application[6]. - The company faces potential risks of termination of listing if it is declared bankrupt following a failed restructuring[6]. - Significant fluctuations in the commodity pig market prices and risks from diseases like African swine fever may have a major impact on the company's operational performance[7]. Future Reporting - The preliminary estimates provided in the earnings forecast will be detailed in the Q1 2025 report[7].